vorasidenib
servier
['vorasidenib', 'indigo']
results of the indigo study are out &amp; will be presented today at the asco plenary! vorasidenib prolongs pfs and can delay the use of chemotherapy/radiation in patients with idh-mutant grade 2 glioma. great day for patients and for the field! #asco23 #btsm #braintumors 
Neurologist @HopPitieSalpe @APHP @Sorbonne_Univ_ & @ParisBrainInst working on brain tumors